About
Sutro Biopharma is a clinical-stage biotechnology company focused on discovering, developing, and manufacturing precisely designed cancer therapeutics. They leverage a proprietary cell-free protein synthesis platform, XpressCF®, to create novel antibody-drug conjugates (ADCs) and other protein-based therapies aimed at improving patient outcomes in oncology.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Sutro Biopharma do?
Sutro Biopharma is a clinical-stage biotechnology company focused on discovering, developing, and manufacturing precisely designed cancer therapeutics. They leverage a proprietary cell-free protein synthesis platform, XpressCF®, to create novel antibody-drug conjugates (ADCs) and other protein-based therapies aimed at improving patient outcomes in oncology.
How much funding has Sutro Biopharma raised?
Sutro Biopharma has raised a total of $296M in funding. The most recent round on record is Public Offering.
When was Sutro Biopharma founded?
Sutro Biopharma was founded in 2003.